These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 17301785

  • 1. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
    Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD.
    Nature; 2007 Feb 15; 445(7129):732-7. PubMed ID: 17301785
    [Abstract] [Full Text] [Related]

  • 2. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
    Richard J, Pacheco B, Gohain N, Veillette M, Ding S, Alsahafi N, Tolbert WD, Prévost J, Chapleau JP, Coutu M, Jia M, Brassard N, Park J, Courter JR, Melillo B, Martin L, Tremblay C, Hahn BH, Kaufmann DE, Wu X, Smith AB, Sodroski J, Pazgier M, Finzi A.
    EBioMedicine; 2016 Oct 15; 12():208-218. PubMed ID: 27633463
    [Abstract] [Full Text] [Related]

  • 3. Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.
    Wu L, Zhou T, Yang ZY, Svehla K, O'Dell S, Louder MK, Xu L, Mascola JR, Burton DR, Hoxie JA, Doms RW, Kwong PD, Nabel GJ.
    J Virol; 2009 May 15; 83(10):5077-86. PubMed ID: 19264769
    [Abstract] [Full Text] [Related]

  • 4. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J, Tran K, Kong L, Dey B, McKee K, Schief W, Kwong PD, Mascola JR, Wyatt RT.
    J Virol; 2014 Dec 15; 88(24):14002-16. PubMed ID: 25253346
    [Abstract] [Full Text] [Related]

  • 5. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
    Koch M, Pancera M, Kwong PD, Kolchinsky P, Grundner C, Wang L, Hendrickson WA, Sodroski J, Wyatt R.
    Virology; 2003 Sep 01; 313(2):387-400. PubMed ID: 12954207
    [Abstract] [Full Text] [Related]

  • 6. Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
    Utachee P, Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M.
    J Virol; 2010 May 01; 84(9):4311-20. PubMed ID: 20164234
    [Abstract] [Full Text] [Related]

  • 7. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P, Moore JP, Thali M, Sodroski J, Barbas CF, Burton DR.
    J Virol; 1994 Aug 01; 68(8):4821-8. PubMed ID: 7518527
    [Abstract] [Full Text] [Related]

  • 8. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, Mertens M, Herschhorn A, Melillo B, Smith AB, Sodroski J.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881646
    [Abstract] [Full Text] [Related]

  • 9. Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
    Chen L, Kwon YD, Zhou T, Wu X, O'Dell S, Cavacini L, Hessell AJ, Pancera M, Tang M, Xu L, Yang ZY, Zhang MY, Arthos J, Burton DR, Dimitrov DS, Nabel GJ, Posner MR, Sodroski J, Wyatt R, Mascola JR, Kwong PD.
    Science; 2009 Nov 20; 326(5956):1123-7. PubMed ID: 19965434
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J.
    Nature; 2002 Dec 12; 420(6916):678-82. PubMed ID: 12478295
    [Abstract] [Full Text] [Related]

  • 11. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 12; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 12. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.
    Acharya P, Luongo TS, Georgiev IS, Matz J, Schmidt SD, Louder MK, Kessler P, Yang Y, McKee K, O'Dell S, Chen L, Baty D, Chames P, Martin L, Mascola JR, Kwong PD.
    J Virol; 2013 Sep 12; 87(18):10173-81. PubMed ID: 23843638
    [Abstract] [Full Text] [Related]

  • 13. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S, Li Y, Kozyrev Y, Cleveland B, Hu SL.
    J Virol; 2016 Jan 15; 90(2):829-41. PubMed ID: 26512079
    [Abstract] [Full Text] [Related]

  • 14. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
    Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, Hastings R, Wessling HC, Norcross MA, Fendly BM, Berman PW.
    J Virol; 1993 Oct 15; 67(10):6179-91. PubMed ID: 7690420
    [Abstract] [Full Text] [Related]

  • 15. Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer.
    Tolbert WD, Nguyen DN, Tehrani ZR, Sajadi MM, Pazgier M.
    mBio; 2021 Aug 31; 12(4):e0127421. PubMed ID: 34281393
    [Abstract] [Full Text] [Related]

  • 16. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.
    Rathore U, Purwar M, Vignesh VS, Das R, Kumar AA, Bhattacharyya S, Arendt H, DeStefano J, Wilson A, Parks C, La Branche CC, Montefiori DC, Varadarajan R.
    J Biol Chem; 2018 Sep 28; 293(39):15002-15020. PubMed ID: 30093409
    [Abstract] [Full Text] [Related]

  • 17. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein.
    Thali M, Furman C, Ho DD, Robinson J, Tilley S, Pinter A, Sodroski J.
    J Virol; 1992 Sep 28; 66(9):5635-41. PubMed ID: 1380099
    [Abstract] [Full Text] [Related]

  • 18. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
    Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, Finzi A, Kwon YD, Scheid JF, Shi W, Xu L, Yang Y, Zhu J, Nussenzweig MC, Sodroski J, Shapiro L, Nabel GJ, Mascola JR, Kwong PD.
    Science; 2010 Aug 13; 329(5993):811-7. PubMed ID: 20616231
    [Abstract] [Full Text] [Related]

  • 19. Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.
    Wu X, Wang C, O'Dell S, Li Y, Keele BF, Yang Z, Imamichi H, Doria-Rose N, Hoxie JA, Connors M, Shaw GM, Wyatt RT, Mascola JR.
    J Virol; 2012 May 13; 86(10):5844-56. PubMed ID: 22419808
    [Abstract] [Full Text] [Related]

  • 20. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
    Kassa A, Dey AK, Sarkar P, Labranche C, Go EP, Clark DF, Sun Y, Nandi A, Hartog K, Desaire H, Montefiori D, Carfi A, Srivastava IK, Barnett SW.
    PLoS One; 2013 May 13; 8(10):e76139. PubMed ID: 24146829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.